SNORD113-7: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD113-7

NCBI ID: G767567

SNORD113-7

Other Name(s): Small nucleolar RNA, C/D box 113-7 | small nucleolar RNA, C/D box 113-7 | 14q(I-7)

SNORD113-7: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to help ensure the stability and translation of mRNAs into the cytoplasm, which is essential for protein synthesis. MBND1 (MutL1-Binding Partner 1) is a well-known snRNA that is expressed in various tissues and plays a central role in the regulation of gene expression.

Recent studies have identified SNORD113-7, a non-coding RNA molecule that is highly expressed in various tissues and is highly conserved across different species. The C/D box 113-7 region of SNORD113-7 is unique and is highly conserved across different species, which suggests that it may be an important molecule for the regulation of gene expression.

Potential Drug Target

The C/D box 113-7 region of SNORD113-7 is a potential drug target. The C/D region is involved in the formation of a base-pair with another non-coding RNA molecule, MBND1. MBND1 has been shown to play a critical role in the regulation of gene expression and has been identified as a potential drug target in various diseases, including cancer.

The C/D box 113-7 region of SNORD113-7 is conserved across different species, which suggests that it may be a conserved region that is involved in the regulation of gene expression. This suggests that targeting this region may be a promising strategy for the development of new drugs that can inhibit the activity of MBND1 and potentially treat various diseases.

Biomarker

SNORD113-7 has also been identified as a potential biomarker for several diseases. The C/D box 113-7 region of SNORD113-7 is highly expressed in various tissues, including brain, heart, and muscle. This suggests that it may be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

The conservation of the C/D box 113-7 region across different species also suggests that it may be a useful biomarker for identifying genetic differences between different populations. This could be useful for the development of targeted therapies that are specific to certain genetic profiles.

Conclusion

SNORD113-7 is a non-coding RNA molecule that is conserved across different species and has been identified as a potential drug target and biomarker. The C/D box 113-7 region of SNORD113-7 is involved in the regulation of gene expression and has been shown to play a critical role in the regulation of protein synthesis. Targeting this region may be a promising strategy for the development of new drugs that can inhibit the activity of MBND1 and potentially treat various diseases. Further research is needed to fully understand the role of SNORD113-7 in the regulation of gene expression and its potential as a drug target and biomarker.

Protein Name: Small Nucleolar RNA, C/D Box 113-7

The "SNORD113-7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD113-7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets